Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The study identifies the indolizino[1,2-b]quinolinone scaffold as a promising framework for dual PDE1B/PDE10A inhibition
Globally, the GLP-1 receptor agonist market is valued at USD 62.86 billion in 2025, projected to surge at a 17.5% compound annual growth rate (CAGR) through 2034, driven by expanding indications for obesity, cardiovascular benefits, and even potential neuroprotective effects
The negative study outcome is a setback for Gileads cancer aspirations
These chemically altered fats were designed to last longer, improve texture, and increase shelf life
This signal did not appear in Phase 2 data, making it something researchers are watching closely across the remaining TRIUMPH trials
US$ 25.49
US$ 23.61
US$ 28.04
US$ 22.46
US$ 26.23
US$ 25.94
US$ 24.29
US$ 27.43
US$ 24.36
US$ 27.73
